Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gurevich

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Pediatric Nephrology (Berlin, Germany)|September 25, 2024
An innocent bystander or a predisposing culprit? Kidney injury following pediatric liver transplantationAdi Glass, Ori Goldberg, Yael Mozer-Glassberg, et al.
Mycoses|April 18, 2018
Risk factors for early invasive fungal infections in paediatric liver transplant recipientsYehonatan Pasternak, Shiri Rubin, Efraim Bilavsky, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Brain Communications|January 9, 2025
Machine learning-based prediction of disease progression in primary progressive multiple sclerosisMichael Gurevich, Rina Zilkha-Falb, Jia Sherman, et al.
Therapeutic Advances in Neurological Disorders|June 9, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Artificial Organs|April 17, 2020
Flow-controlled fluoroscopic angiography for the assessment of vascular integrity in bioengineered kidneysShahar Cohen, Sarit Soffer-Hirschberg, Shirly Partouche, et al.
Scientific Reports|November 3, 2024
Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout miceAdi Har-Zahav, Ana Tobar, Sophia Fried, et al.
Nephron|July 31, 2022
The Role of Early Sequential Biopsies in Delayed Renal Graft Function of Transplanted Kidney Is Reduced in Modern Immunosuppression EraOhad Guetta, Anton Osyntsov, Ruth Rahamimov, et al.
Multiple Sclerosis and Related Disorders|March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumabAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Pediatric Nephrology (Berlin, Germany)|September 25, 2024
An innocent bystander or a predisposing culprit? Kidney injury following pediatric liver transplantationAdi Glass, Ori Goldberg, Yael Mozer-Glassberg, et al.
Mycoses|April 18, 2018
Risk factors for early invasive fungal infections in paediatric liver transplant recipientsYehonatan Pasternak, Shiri Rubin, Efraim Bilavsky, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Brain Communications|January 9, 2025
Machine learning-based prediction of disease progression in primary progressive multiple sclerosisMichael Gurevich, Rina Zilkha-Falb, Jia Sherman, et al.
Therapeutic Advances in Neurological Disorders|June 9, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Artificial Organs|April 17, 2020
Flow-controlled fluoroscopic angiography for the assessment of vascular integrity in bioengineered kidneysShahar Cohen, Sarit Soffer-Hirschberg, Shirly Partouche, et al.
Scientific Reports|November 3, 2024
Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout miceAdi Har-Zahav, Ana Tobar, Sophia Fried, et al.
Nephron|July 31, 2022
The Role of Early Sequential Biopsies in Delayed Renal Graft Function of Transplanted Kidney Is Reduced in Modern Immunosuppression EraOhad Guetta, Anton Osyntsov, Ruth Rahamimov, et al.
Multiple Sclerosis and Related Disorders|March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumabAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Pageof 10